Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Xetra  >  BASF SE    BAS   DE000BASF111


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

BASF : Tackling Malaria Through a Two-Barrel Approach of Mosquito Nets

share with twitter share with LinkedIn share with facebook
share via e-mail
10/10/2019 | 08:06am EST

Close to half a million people die from malaria each year according to the World Health Organisation, and that number could rise due to growing resistance to pesticides. But one UK-based company is hoping to beat that with a two-barrel approach.

As governments, companies and private donations respond to The Global Fund's call to meet its 14 billion US target to continue its fight against HIV, Tuberculosis and Malaria, innovations dependent on the funds have a chance to showcase their projects during these two days in Lyon.

One in particular is a new approach to mosquito nets.

"Most mosquito nets have one insecticide in the, and this one has two, which means that the mosquito is hit from two different directions with two different modalities of operation and that's what makes the difference," explains Michael Anderson, the CEO of MedAccess, a UK-based company that supports projects worldwide to "achieve global health goals."

In conjunction with the Bill and Melinda Gates Foundation and BASF, a German chemical company, MedAccess is supporting this mosquito net that took six years to develop adds Anderson.

Resistance to insecticide

The problem in eradicating malaria has been the very mosquitos that spread the disease. "The challenge for all of us, is managing as mosquitos evolve and they develop resistance to new techniques."

That means the current net is not as powerful as before in killing the insects, although the net itself still remains a helpful barrier for those sleeping beneath it.

This product tries to address this problem by blending two active ingredients, making it "much harder for the mosquito to evolve in a way that will response to both active ingredients simultaneously," explains the CEO.

It's easier for a mosquito to evolve and develop a resistance to one active ingredient, but two? It's much harder adds Anderson, noting "that's why we think this net is going to last for some time".

The new ingredient, called Interceptor G2 has two classes of insecticide. One of them is pyrethroids, which is already used in nets, and the second is chlorfenapyr, one that is "widely used on crops, used for killing insects in households," and has been in circulation since the 1960s says Anderson.

Wear and tear

Although nets have been proven to help block mosquitos access to humans, they inevitably break down and need to be replaced.

And that takes money.

"Most countries run a campaign every three years, it's a common pattern to replace all the nets every three years," explains Anderson. "The nets are designed to be active after at least 20 washes, they're designed to be that durable."

Which is why access to funds, in this case coming from The Global Fund, governments can support those big campaigns to replace the nets.

In areas where malaria is more prevalent, the climate is normally wetter and humid, a factor that could also contribute to a shorter life time of these new nets.

"They [the new nets] seem to have really good resilience. Of course these nets are new, they're on the market. They've been tested many times, and the testing shows really strong resilience. But we'll have to see in the field what actually happens."

Cost of the net

Even if governments actively provide access to nets, there is still a cost. And in this case, the cost is inevitably higher.

"The partnership that we've had with BASF and the Bill and Melinda Gates Foundation; the three of us have put together this package to bring down the prices of this new net, closer to the price of existing nets." Anderson says that was a 40 percent drop from the original price, but it's not as inexpensive as the net with just one insecticide.

He adds that the key to bringing down the cases of malaria, particularly in West Africa is finding new methods of tackling mosquitos.

Copyright Radio France Internationale. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on BASF SE
04:16aMARKET-READY AND CERTIFIED : insulation raw material Neopor® from BASF with sign..
12/06SCHNEIDER ELECTRIC : increases visibility into operations with the implementatio..
12/05BASF : to double production capacity of automotive refinish coatings at Jiangmen..
12/04Oil companies swap stakes in Mexico as government holds off on auctions
11/28A union between Orange and Deutsche Telekom?
11/27EXCLUSIVE : Lone Star in exclusive talks to buy BASF construction chemicals unit..
11/27IPO candidate Wintershall Dea raises 2019 production outlook
11/26UTRECHT UNIVERSITY : 'Collaboration is an essential condition for this degree of..
11/23BASF : Germany's BASF starts building $10-billion petrochemical project in China
11/23BASF : commences its smart Verbund project in Zhanjiang, China
More news
Financials (EUR)
Sales 2019 61 943 M
EBIT 2019 4 723 M
Net income 2019 9 118 M
Debt 2019 18 540 M
Yield 2019 4,79%
P/E ratio 2019 6,79x
P/E ratio 2020 17,4x
EV / Sales2019 1,30x
EV / Sales2020 1,25x
Capitalization 62 264 M
Duration : Period :
BASF SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BASF SE
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 26
Average target price 66,44  €
Last Close Price 67,79  €
Spread / Highest target 29,8%
Spread / Average Target -1,99%
Spread / Lowest Target -29,3%
EPS Revisions
Martin Brudermüller Chairman-Executive Board & CTO
Jürgen Hambrecht Chairman-Supervisory Board
Hans-Ulrich Engel CFO & Vice Chairman-Executive Board
Michael Diekmann Vice Chairman-Supervisory Board
François Diederich Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BASF SE12.24%68 937
DUPONT DE NEMOURS, INC.-14.62%47 293
ROYAL DSM63.14%21 793